StockData
ARS Pharmaceuticals, Inc. logo

ARS Pharmaceuticals, Inc. (SPRY) stock

SPRYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$3.65+0.06 (+1.67%)

Close on Nov 17, 2026Market cap $362.98MP/E –Yield –

ARS Pharmaceuticals price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

ARS Pharmaceuticals's price to book ratio was 31.4× on Nov 11, 2026, against 6.4× a year earlier. Over the last 5 years it ranged from 0.5× to 47.7×, with a median of 4.6×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202631.4×+23.6
2025Dec 31, 20257.8×+2.7
2024Dec 31, 20245.1×+2.9
2023Dec 29, 20232.2×+1.7
2022Jan 31, 20220.5×−0.2
2021Dec 31, 20210.7×–

More ARS Pharmaceuticals figures

See a number that looks wrong?